GT200200115AA - PHARMACEUTICAL FORMULATION OF MASKED FLAVOR AND PROCEDURE FOR PREPARATION. - Google Patents
PHARMACEUTICAL FORMULATION OF MASKED FLAVOR AND PROCEDURE FOR PREPARATION.Info
- Publication number
- GT200200115AA GT200200115AA GT200200115AK GT200200115K GT200200115AA GT 200200115A A GT200200115A A GT 200200115AA GT 200200115A K GT200200115A K GT 200200115AK GT 200200115 K GT200200115 K GT 200200115K GT 200200115A A GT200200115A A GT 200200115AA
- Authority
- GT
- Guatemala
- Prior art keywords
- procedure
- preparation
- pharmaceutical formulation
- flavor
- well
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UNA FORMULACION FARMACEUTICA EN FORMA DE POLVO, DESTINADA A SER ADMINISTRADA EN SUSPENSION ACUOSA POR VIA ORAL, QUE ENMASCARA SU SABOR Y QUE INCLUYE POR LO MENOS UN POLIMERO CELULOSICO, UN POLIMERO METACRILICO Y UN PRINCIPIO ACTIVO DISTRIBUIDO DE MANERA HOMOGENEA Y EN ESTADO MOLECULAR EN UNA MATRIZ ATOMIZADA, ASI COMO UN AGENTE ALCALINO Y UN AGENTE ADSORBENTE, AL PROCEDIMIENTO PARA SU PREPARACION, ASI COMO A UN METODO DE ENMASCARAMIENTO DEL SABOR DE PRODUCTOS FARMACEUTICOS.THE PRESENT INVENTION REFERS TO A PHARMACEUTICAL FORMULATION IN THE FORM OF POWDER, INTENDED TO BE ADMINISTERED IN A WATERPROOF SUSPENSION BY ORAL ROUTE, THAT WILL MASK YOUR FLAVOR AND THAT INCLUDES AT LEAST A CELLULOSIC POLYMER, A METACRYLIC POLYMER AND A MANUAL HOG PRINCIPLE AND IN MOLECULAR STATE IN AN ATOMIZED MATRIX, AS WELL AS AN ALKALINE AGENT AND AN ADSORBENT AGENT, TO THE PROCEDURE FOR THEIR PREPARATION, AS WELL AS TO A MASKING METHOD OF THE FLAVOR OF PHARMACEUTICAL PRODUCTS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0108157A FR2826274B1 (en) | 2001-06-21 | 2001-06-21 | PHARMACEUTICAL FORMULATION FOR MASK TASTE AND METHOD FOR PREPARING THE SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200200115AA true GT200200115AA (en) | 2005-01-12 |
Family
ID=8864587
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200200115AK GT200200115AA (en) | 2001-06-21 | 2002-06-11 | PHARMACEUTICAL FORMULATION OF MASKED FLAVOR AND PROCEDURE FOR PREPARATION. |
| GT200200115A GT200200115A (en) | 2001-06-21 | 2002-06-11 | PHARMACEUTICAL FORMULATION OF MASKED FLAVOR AND PROCEDURE FOR PREPARATION |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200200115A GT200200115A (en) | 2001-06-21 | 2002-06-11 | PHARMACEUTICAL FORMULATION OF MASKED FLAVOR AND PROCEDURE FOR PREPARATION |
Country Status (41)
| Country | Link |
|---|---|
| US (2) | US7138138B2 (en) |
| EP (1) | EP1401397B1 (en) |
| JP (1) | JP4880871B2 (en) |
| CN (1) | CN1239149C (en) |
| AP (1) | AP1595A (en) |
| AR (1) | AR036096A1 (en) |
| AT (1) | ATE290366T1 (en) |
| AU (1) | AU2002329311B2 (en) |
| BG (1) | BG66314B1 (en) |
| BR (1) | BRPI0208998A2 (en) |
| CA (1) | CA2452239C (en) |
| CO (1) | CO5540278A2 (en) |
| CZ (1) | CZ299947B6 (en) |
| DE (1) | DE60203178T2 (en) |
| EA (1) | EA006016B1 (en) |
| EC (1) | ECSP034915A (en) |
| ES (1) | ES2236574T3 (en) |
| FR (1) | FR2826274B1 (en) |
| GT (2) | GT200200115AA (en) |
| HR (1) | HRP20031067B1 (en) |
| HU (1) | HUP0400799A3 (en) |
| IL (2) | IL159404A0 (en) |
| JO (1) | JO2325B1 (en) |
| MA (1) | MA27042A1 (en) |
| MX (1) | MXPA03011756A (en) |
| MY (1) | MY134340A (en) |
| NO (1) | NO332258B1 (en) |
| NZ (1) | NZ530042A (en) |
| OA (1) | OA12635A (en) |
| PA (1) | PA8548301A1 (en) |
| PE (1) | PE20030201A1 (en) |
| PL (1) | PL202090B1 (en) |
| PT (1) | PT1401397E (en) |
| SK (1) | SK285865B6 (en) |
| SV (1) | SV2003001098A (en) |
| TN (1) | TNSN03141A1 (en) |
| TW (1) | TWI228049B (en) |
| UA (1) | UA77960C2 (en) |
| UY (1) | UY27341A1 (en) |
| WO (1) | WO2003000225A2 (en) |
| ZA (1) | ZA200309479B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7384921B2 (en) * | 2004-02-20 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | Polymorphic forms of 6-11 bicyclic ketolide derivatives |
| GB2419094A (en) * | 2004-10-12 | 2006-04-19 | Sandoz Ag | Pharmaceutical composition of unpleasnt tasing active substances |
| FR2882522B1 (en) * | 2005-02-25 | 2007-04-13 | Aventis Pharma Sa | SOLID PHARMACEUTICAL COMPOSITION COMPRISING TELITHROMYCIN |
| US7384922B2 (en) * | 2005-05-04 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | 6-11 bridged oxime erythromycin derivatives |
| US20060264386A1 (en) * | 2005-05-17 | 2006-11-23 | Rongqi Sun | Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof |
| WO2007090721A1 (en) * | 2006-02-03 | 2007-08-16 | Evonik Röhm Gmbh | Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water |
| US20100226979A1 (en) * | 2006-03-21 | 2010-09-09 | Jubilant Organosys Limited | Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate |
| US20080181932A1 (en) * | 2007-01-30 | 2008-07-31 | Drugtech Corporation | Compositions for oral delivery of pharmaceuticals |
| KR100935893B1 (en) * | 2007-09-11 | 2010-01-07 | 국방과학연구소 | Synthesis of 1,1'-dimethyl-5,5'-bitetrazole |
| JP5698979B2 (en) | 2007-10-25 | 2015-04-08 | センプラ ファーマシューティカルズ，インコーポレイテッド | Process for preparing macrolide antibacterial agents |
| WO2010069330A2 (en) | 2008-12-16 | 2010-06-24 | Carlsberg A/S | Coating of hydroxylated surfaces by gas phase grafting |
| WO2013148891A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
| DE102012014848A1 (en) * | 2012-07-27 | 2012-10-31 | Heilerde-Gesellschaft Luvos Just GmbH & Co. KG | Healing clay-composition present as non-coated or as coated granules, comprises healing clay and binding agent containing at least one water soluble polymer e.g. starch, tragacanth or cellulose acetate, cellulose ether |
| MX2017001569A (en) * | 2014-08-05 | 2017-08-07 | Cempra Pharmaceuticals Inc | Powder oral suspension formulations of antibacterial agents. |
| US10982177B2 (en) | 2017-09-18 | 2021-04-20 | The Clorox Company | Cleaning wipes with particular lotion retention and efficacy characteristics |
| CN114209661B (en) * | 2022-02-21 | 2022-04-29 | 北京罗诺强施医药技术研发中心有限公司 | Solid pharmaceutical composition in the form of granules |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2930409A1 (en) * | 1979-07-26 | 1981-02-12 | Bayer Ag | SPRAY DRYING OF MICROCAPSEL DISPERSIONS |
| JPS63150220A (en) * | 1986-12-15 | 1988-06-22 | Dainippon Pharmaceut Co Ltd | Preparation of solid drug for oral administration |
| US4808411A (en) * | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
| US5084278A (en) * | 1989-06-02 | 1992-01-28 | Nortec Development Associates, Inc. | Taste-masked pharmaceutical compositions |
| ZA945944B (en) * | 1993-08-13 | 1996-02-08 | Eurand America Inc | Procedure for encapsulating nsaids |
| AUPN969796A0 (en) * | 1996-05-07 | 1996-05-30 | F.H. Faulding & Co. Limited | Taste masked liquid suspensions |
| JP2001518490A (en) * | 1997-10-03 | 2001-10-16 | エラン コーポレーシヨン ピーエルシー | Taste-masked preparation |
| IN191239B (en) * | 1999-06-11 | 2003-10-11 | Ranbaxy Lab Ltd | |
| US6555569B2 (en) * | 2000-03-07 | 2003-04-29 | Pfizer Inc. | Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection |
| WO2002016380A1 (en) * | 2000-08-22 | 2002-02-28 | Basilea Pharmaceutica Ag | New macrolides with antibacterial activity |
-
2001
- 2001-06-21 FR FR0108157A patent/FR2826274B1/en not_active Expired - Fee Related
-
2002
- 2002-05-08 TW TW091109613A patent/TWI228049B/en not_active IP Right Cessation
- 2002-05-09 JO JO200241A patent/JO2325B1/en active
- 2002-06-11 GT GT200200115AK patent/GT200200115AA/en unknown
- 2002-06-11 GT GT200200115A patent/GT200200115A/en unknown
- 2002-06-17 MY MYPI20022250A patent/MY134340A/en unknown
- 2002-06-18 PE PE2002000522A patent/PE20030201A1/en not_active Application Discontinuation
- 2002-06-18 UY UY27341A patent/UY27341A1/en not_active Application Discontinuation
- 2002-06-19 PA PA20028548301A patent/PA8548301A1/en unknown
- 2002-06-19 AR ARP020102300A patent/AR036096A1/en not_active Application Discontinuation
- 2002-06-19 SV SV2002001098A patent/SV2003001098A/en not_active Application Discontinuation
- 2002-06-21 TN TNPCT/FR2002/002158A patent/TNSN03141A1/en unknown
- 2002-06-21 OA OA1200300340A patent/OA12635A/en unknown
- 2002-06-21 PL PL366803A patent/PL202090B1/en unknown
- 2002-06-21 IL IL15940402A patent/IL159404A0/en active IP Right Grant
- 2002-06-21 PT PT02764922T patent/PT1401397E/en unknown
- 2002-06-21 HU HU0400799A patent/HUP0400799A3/en unknown
- 2002-06-21 SK SK1592-2003A patent/SK285865B6/en not_active IP Right Cessation
- 2002-06-21 NZ NZ530042A patent/NZ530042A/en not_active IP Right Cessation
- 2002-06-21 DE DE60203178T patent/DE60203178T2/en not_active Expired - Lifetime
- 2002-06-21 WO PCT/FR2002/002158 patent/WO2003000225A2/en active IP Right Grant
- 2002-06-21 CZ CZ20033441A patent/CZ299947B6/en not_active IP Right Cessation
- 2002-06-21 BR BRPI0208998A patent/BRPI0208998A2/en not_active IP Right Cessation
- 2002-06-21 MX MXPA03011756A patent/MXPA03011756A/en active IP Right Grant
- 2002-06-21 AU AU2002329311A patent/AU2002329311B2/en not_active Ceased
- 2002-06-21 JP JP2003506872A patent/JP4880871B2/en not_active Expired - Fee Related
- 2002-06-21 CA CA2452239A patent/CA2452239C/en not_active Expired - Fee Related
- 2002-06-21 AP APAP/P/2003/002927A patent/AP1595A/en active
- 2002-06-21 UA UA2004010425A patent/UA77960C2/en unknown
- 2002-06-21 ES ES02764922T patent/ES2236574T3/en not_active Expired - Lifetime
- 2002-06-21 EP EP02764922A patent/EP1401397B1/en not_active Expired - Lifetime
- 2002-06-21 EA EA200400061A patent/EA006016B1/en not_active IP Right Cessation
- 2002-06-21 HR HR20031067A patent/HRP20031067B1/en not_active IP Right Cessation
- 2002-06-21 CN CNB028121465A patent/CN1239149C/en not_active Expired - Fee Related
- 2002-06-21 AT AT02764922T patent/ATE290366T1/en active
-
2003
- 2003-12-05 ZA ZA2003/09479A patent/ZA200309479B/en unknown
- 2003-12-12 US US10/735,538 patent/US7138138B2/en not_active Expired - Lifetime
- 2003-12-15 NO NO20035581A patent/NO332258B1/en not_active IP Right Cessation
- 2003-12-16 MA MA27445A patent/MA27042A1/en unknown
- 2003-12-16 BG BG108458A patent/BG66314B1/en unknown
- 2003-12-16 IL IL159404A patent/IL159404A/en not_active IP Right Cessation
- 2003-12-18 EC EC2003004915A patent/ECSP034915A/en unknown
- 2003-12-19 CO CO03111139A patent/CO5540278A2/en active IP Right Grant
-
2006
- 2006-09-20 US US11/533,573 patent/US20070014857A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200200115AA (en) | PHARMACEUTICAL FORMULATION OF MASKED FLAVOR AND PROCEDURE FOR PREPARATION. | |
| BR0112495A (en) | Dosage form, process for producing a dosage form and use of the dosage form | |
| HRP20060147B1 (en) | CONTROLLED RELEASE THERAPY SYSTEM FOR Oral Use | |
| BR0112054A (en) | Micelle-forming composition, and methods for administration and protection of a therapeutic agent | |
| BRPI0620063B8 (en) | sustained release pharmaceutical composition in the form of microparticles, usage, and administration kit | |
| BR9808888A (en) | Dosage forms and method of improving male erectile dysfunction | |
| BR0112311A (en) | Active agent release compounds and compositions, unit dosage form, method for preparing said compositions and their use | |
| DE122011100049I1 (en) | Stable pharmaceutical solution formulations for pressurized inhalers for the administration of metered doses. | |
| WO2008118133A3 (en) | Silk microspheres for encapsulation and controlled release | |
| AR029655A1 (en) | IMPROVEMENTS IN FORMULATIONS IN PASTA | |
| BR0009604A (en) | Overcoated chewing gum formulations | |
| ATE355065T1 (en) | THERAPEUTIC COMPOSITIONS CONSISTING OF ANTIHYPOTENSIVES AND ANTIANGIOGENICS | |
| NO20075136L (en) | New liposome preparations | |
| BR0114799A (en) | Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents | |
| WO2003035051A3 (en) | The use of proton sequestering agents in drug formulations | |
| CR8371A (en) | DRUG FORMULATIONS CONTAINING FLAVORS WITH BETTER PHARMACEUTICAL PROPERTIES | |
| BR0306501A (en) | Method for use and production of a medicated buffer | |
| CL2007003331A1 (en) | METHOD TO TREAT CANCER THROUGH THE ADMINISTRATION OF A BENZO RADIOSENSIBILIZING AGENT [A] TRINDEN-4,6-DIONA; PHARMACEUTICAL COMPOSITION UNDERSTANDING THIS AGENT. | |
| AR048050A1 (en) | MASTICABLE, NON-COMPRESSED, METHODS OF ADMINISTRATION INDIVIDUALLY DOSED | |
| AR024564A1 (en) | COMPOSITION THAT INCLUDES SPPHINGOMYELINASE FOR USE AS A DIETARY PREPARATION, DIETARY SUPPLEMENT OR PHARMACEUTICAL PRODUCT | |
| PE20030323A1 (en) | PHARMACEUTICAL COMPOSITION | |
| DE60140997D1 (en) | THERAPEUTIC COMPOSITIONS FOR PULMONARY ADMINISTRATION | |
| BRPI0506630A (en) | controlled release composition and method for administering a controlled release transmucosal aqueous drug | |
| AR047480A1 (en) | COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF OSEAS METABOLIC DISEASES; PROCESS OF PREPARATION AND USE OF THIS COMPOSITION | |
| PE20050443A1 (en) | TRANSDERMAL PHARMACEUTICAL FORMULATIONS |